The Ministry of Health has announced a temporary disruption in the supply of the rotavirus vaccine, a key component of Kenya’s routine immunisation programme for infants. The rotavirus vaccine, administered orally, protects young children from severe diarrhoea, vomiting, and dehydration caused by rotavirus infections. It is given to infants at six, ten, and fourteen weeks of age as part of the national immunisation schedule.
Reason for the Shortage
In a statement on Thursday, Health Cabinet Secretary Aden Duale revealed that the Rotavac Frozen vaccine is in short supply. The shortage follows a notification from Gavi, the Vaccine Alliance, indicating that the manufacturer, Bharat Biotech, is experiencing production delays due to facility upgrades. These delays are expected to impact vaccine deliveries globally between 2026 and 2027. As of March 3, 2026, the Ministry reported only about 4,000 doses remaining at the national level—enough for less than a month. A shipment originally expected in January 2026 has been postponed, with the next expected delivery now projected for the end of April 2026.
Measures to Minimise Disruption
The Ministry of Health is working closely with UNICEF and other partners to:
- Fast-track the arrival of new vaccine shipments
- Redistribute available doses equitably across counties
- Monitor stock levels to reduce the impact on routine immunisation services
Parents and caregivers are encouraged to continue taking children for routine immunisation visits despite the shortage. CS Duale also urged families to reinforce hygiene measures, including:
- Regular handwashing with soap
- Treating drinking water
- Safe food handling
- Maintaining clean household environments
He assured the public that the government is collaborating with global partners to restore normal vaccine supply.
